TAK1 blockade as a therapy for retinal neovascularization
F.-L. Lin, J.-H. Wang, J. Chen, L. Zhu, Y.-F. Chuang, L. Tu, C. Ma, S. Lama, D. Ling, R. C.-B. Wong, A. W. Hewitt, C.-L. Tseng, B. V. Bui, P. van Wijngaarden, G. J. Dusting, , G.-S. Liu
This study investigates TAK1's role in retinal neovascularization and shows that inhibiting TAK1 reduces aberrant angiogenesis in a rat model.
bioRxiv · Jan 29, 2021Biochemistry